Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biosimilars Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celltrion Inc
Pfizer Inc
Intas Pharmaceuticals Ltd
STADA Arzneimittel AG
Dr Reddy's Laboratories Ltd
By Type:
Recombinant Non – Glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
By Application:
Growth Hormone Disease
Infectious Disease
Oncology
Blood Disorders
Chronic and Autoimmune Disease
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilars Treatment Market Overview 2018-2029
-
1.1 China Biosimilars Treatment Industry Development Overview
-
1.2 China Biosimilars Treatment Industry Development History
-
1.3 China Biosimilars Treatment Industry Market Size (2018-2029)
-
1.4 China Biosimilars Treatment Market Analysis by Type from Production Side
-
1.4.1 China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Non – Glycosylated Proteins (2018-2029)
-
1.4.2 China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Glycosylated Proteins (2018-2029)
-
1.4.3 China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Peptides (2018-2029)
-
1.5 China Biosimilars Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Growth Hormone Disease (2018-2029)
-
1.5.2 China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)
-
1.5.3 China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.5.4 China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)
-
1.5.5 China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Chronic and Autoimmune Disease (2018-2029)
-
1.6 China Biosimilars Treatment Market Analysis by Region
-
1.6.1 North China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilars Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilars Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilars Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilars Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilars Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilars Treatment Industry Development
Chapter 3 Biosimilars TreatmentIndustry Chain Analysis
-
3.1 Biosimilars Treatment Industry Chain
-
3.2 Biosimilars Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilars Treatment Market
-
3.3 Biosimilars Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilars Treatment Market
Chapter 4 China Biosimilars Treatment Market, by Type
-
4.1 China Biosimilars Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilars Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilars Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Non – Glycosylated Proteins
-
4.5.2 China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Glycosylated Proteins
-
4.5.3 China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Peptides
Chapter 5 China Biosimilars Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilars Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilars Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilars Treatment Market Size and Growth Rate of Growth Hormone Disease
-
5.5.2 China Biosimilars Treatment Market Size and Growth Rate of Infectious Disease
-
5.5.3 China Biosimilars Treatment Market Size and Growth Rate of Oncology
-
5.5.4 China Biosimilars Treatment Market Size and Growth Rate of Blood Disorders
-
5.5.5 China Biosimilars Treatment Market Size and Growth Rate of Chronic and Autoimmune Disease
Chapter 6 China Biosimilars Treatment Market, by Region
-
6.1 China Biosimilars Treatment Production Volume and Production Value, by Region
-
6.2 China Biosimilars Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilars Treatment Market Analysis
-
7.1 North China Biosimilars Treatment Market, by Type
-
7.2 North China Biosimilars Treatment Market, by Application
Chapter 8 Central China Biosimilars Treatment Market Analysis
-
8.1 Central China Biosimilars Treatment Market, by Type
-
8.2 Central China Biosimilars Treatment Market, by Application
Chapter 9 South China Biosimilars Treatment Market Analysis
-
9.1 South China Biosimilars Treatment Market, by Type
-
9.2 South China Biosimilars Treatment Market, by Application
Chapter 10 East China Biosimilars Treatment Market Analysis
-
10.1 East China Biosimilars Treatment Market, by Type
-
10.2 East China Biosimilars Treatment Market, by Application
Chapter 11 Northeast China Biosimilars Treatment Market Analysis
-
11.1 Northeast China Biosimilars Treatment Market, by Type
-
11.2 Northeast China Biosimilars Treatment Market, by Application
Chapter 12 Southwest China Biosimilars Treatment Market Analysis
-
12.1 Southwest China Biosimilars Treatment Market, by Type
-
12.2 Southwest China Biosimilars Treatment Market, by Application
Chapter 13 Northwest China Biosimilars Treatment Market Analysis
-
13.1 Northwest China Biosimilars Treatment Market, by Type
-
13.2 Northwest China Biosimilars Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Celltrion Inc
-
14.1.1 Celltrion Inc Company Profile
-
14.1.2 Celltrion Inc Biosimilars Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pfizer Inc
-
14.2.1 Pfizer Inc Company Profile
-
14.2.2 Pfizer Inc Biosimilars Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Intas Pharmaceuticals Ltd
-
14.3.1 Intas Pharmaceuticals Ltd Company Profile
-
14.3.2 Intas Pharmaceuticals Ltd Biosimilars Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 STADA Arzneimittel AG
-
14.4.1 STADA Arzneimittel AG Company Profile
-
14.4.2 STADA Arzneimittel AG Biosimilars Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Dr Reddy's Laboratories Ltd
-
14.5.1 Dr Reddy's Laboratories Ltd Company Profile
-
14.5.2 Dr Reddy's Laboratories Ltd Biosimilars Treatment Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilars Treatment Industry Research Conclusions
-
15.2 Biosimilars Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilars Treatment Industry Market Size (2018-2029)
-
Figure China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Non – Glycosylated Proteins (2018-2029)
-
Figure China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Glycosylated Proteins (2018-2029)
-
Figure China Biosimilars Treatment Production Volume, Production Value and Growth Rate of Recombinant Peptides (2018-2029)
-
Figure China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Growth Hormone Disease (2018-2029)
-
Figure China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)
-
Figure China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)
-
Figure China Biosimilars Treatment Sales Volume, Sales Value and Growth Rate of Chronic and Autoimmune Disease (2018-2029)
-
Figure North China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilars Treatment Market Size and Growth Rate from 2018-2029
-
Figure Biosimilars Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilars Treatment Market Share by Type in 2018
-
Figure China Biosimilars Treatment Market Share by Type in 2023
-
Figure China Biosimilars Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Non – Glycosylated Proteins (2018-2023)
-
Figure China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Glycosylated Proteins (2018-2023)
-
Figure China Biosimilars Treatment Production Volume and Growth Rate of Recombinant Peptides (2018-2023)
-
Figure China Biosimilars Treatment Market Share by Application in 2018
-
Figure China Biosimilars Treatment Market Share by Application in 2023
-
Figure China Biosimilars Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilars Treatment Market Size and Growth Rate of Growth Hormone Disease (2018-2023)
-
Figure China Biosimilars Treatment Market Size and Growth Rate of Infectious Disease (2018-2023)
-
Figure China Biosimilars Treatment Market Size and Growth Rate of Oncology (2018-2023)
-
Figure China Biosimilars Treatment Market Size and Growth Rate of Blood Disorders (2018-2023)
-
Figure China Biosimilars Treatment Market Size and Growth Rate of Chronic and Autoimmune Disease (2018-2023)
-
Table China Biosimilars Treatment Production Volume by Region (2018-2023)
-
Table China Biosimilars Treatment Production Volume Share by Region (2018-2023)
-
Figure China Biosimilars Treatment Production Volume Share by Region (2018-2023)
-
Table China Biosimilars Treatment Production Value by Region (2018-2023)
-
Table China Biosimilars Treatment Production Value Share by Region (2018-2023)
-
Figure China Biosimilars Treatment Production Value Share by Region (2018-2023)
-
Table China Biosimilars Treatment Sales Volume by Region (2018-2023)
-
Table China Biosimilars Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilars Treatment Sales Volume Share by Region (2018-2023)
-
Table China Biosimilars Treatment Sales Value by Region (2018-2023)
-
Table China Biosimilars Treatment Sales Value Share by Region (2018-2023)
-
Figure China Biosimilars Treatment Sales Value Share by Region (2018-2023)
-
Table North China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table North China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table North China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table North China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table Central China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table Central China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table South China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table South China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table South China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table East China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table East China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table East China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilars Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilars Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilars Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilars Treatment Sales Volume Share by Application (2018-2023)
-
Table Celltrion Inc Company Profile
-
Table Celltrion Inc Biosimilars Treatment Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Biosimilars Treatment Revenue, Price and Gross (2018-2023)
-
Table Intas Pharmaceuticals Ltd Company Profile
-
Table Intas Pharmaceuticals Ltd Biosimilars Treatment Revenue, Price and Gross (2018-2023)
-
Table STADA Arzneimittel AG Company Profile
-
Table STADA Arzneimittel AG Biosimilars Treatment Revenue, Price and Gross (2018-2023)
-
Table Dr Reddy's Laboratories Ltd Company Profile
-
Table Dr Reddy's Laboratories Ltd Biosimilars Treatment Revenue, Price and Gross (2018-2023)
-
